Replies to post #292828 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The more subgroup data available in the official trial results, the better the chances that later, for other indications, it may be valuable for a general solid tumor approval along the lines of Keytruda, is my guess.

[learningcurve2020]

Some of the data was probably delivered on floppies. lol.

[Doc logic]

exwannabe,

The near future treatment of cancer will be individualized and benefit specific. The more data linking benefit to a specific factor the better, not only for GBM but for all cancers with that marker. Most unmethylated patients who don't respond well to chemo/rad may end up eventually getting DCVax-L much sooner because of this approach. Best wishes.

[CherryTree1]

It is all important
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155118011